Work

Pharmacokinetic and safety study of subcutaneously administered weekly ING-1, a human engineered™ monoclonal antibody targeting human EpCAM, in patients with advanced solid tumors

Year: 2007

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdm280

Authors: S. Goel, R.J. Bauer, K. Desai, A. Bulgaru, T. Iqbal, B.-K. Strachan, G. Kim, A. Kaubisch, G.F. Vanhove, G. Goldberg, S. Mani

Institutions: Albert Einstein College of Medicine, XOMA (United States), Montefiore Medical Center

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2130729810

FWCI: 0.499

Cites: 16

Cited by: 25

Related to: 10